Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01206699
Other study ID # 10/3-N
Secondary ID
Status Terminated
Phase Phase 4
First received September 21, 2010
Last updated November 2, 2015
Start date September 2010
Est. completion date February 2015

Study information

Verified date September 2010
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Afssaps
Study type Interventional

Clinical Trial Summary

The specific aim of this study is to determine whether, when treated with corticoid infiltration, certain chronic lumbagos could be explained by the presence of a neo-articulation.The primary criteria is to determine the difference between the mean pain during the latest 24 hours preceding the infiltration and the mean pain preceding the visit S4 (visit 4 weeks after the infiltration)


Recruitment information / eligibility

Status Terminated
Enrollment 16
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult with age equal or above to 18.

- Subject affiliated to French health insurance (Sécurité Sociale)

- Lateralized lumbago on side of the neo-articulation evolving since more than 3 months

- Mechanical pain, lumbar low level or gluteal without sciatic irradiation (pain above the knee)

- Mean pain during the latest 24 hours above 4 on an analogic visual scale (from 0 to 10)- Pain induced by palpation in regards to the neo-articulation

- Pain not relieved by medical treatment with non steroids anti- inflammatory drugs or antalgics

- No clinical proof for a discal origin : inducing factor, impulsiveness, spinal syndrome, true Lasègue

- transverse-sacral abnormality of IIb, IIIa, IIIc or IV type with neo-articulation lateralized on side of pain

- Informed consent form signed

Exclusion Criteria:

- Age below 18

- Clinical arguments in favour of a discal origin

- Pregnant women or women that could become pregnant the day of the infiltration

- Diabetic patient

- Patient unable to understand the protocol

- No autonomy for coming to the hospital (no budget allocated for patient transportation)

- Hypersensitivity to local anesthetics with "liaison amide"

- Hypersensitivity to one of the components

- Porphyria- Local or generalized infection, suspiscion of infection

- Severe troubles of coagulation, anti-coagulant treatment taken

- Bilateral lumbago with bilateral neo-articulation

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Low Back Pain
  • Subjects Suffering of Lateralized Lumbago on Side of the Malformation (Neo-articulation)

Intervention

Drug:
corticoid (altim® 1.5 ml)
Active arm : anesthetic bloc (1 ml of lidocaïne 1%) immediately followed with corticoid (altim® 1.5 ml)
physiological solution (1.5 ml)
Control arm: anesthetic bloc (1 ml of lidocaïne 1%) immediately followed with physiological solution (1.5 ml)

Locations

Country Name City State
France Hospital of La Roche/Yon La Roche/Yon
France Nantes Hospital Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the difference between the mean pain during the latest 24 hours preceding the infiltration and the mean pain preceding the visit S4 (visit 4 weeks after the infiltration) To determine whether, when treated with corticoid infiltration, certain chronic lumbagos could be explained by the presence of a neo-articulation.The primary criteria is to determine the difference between the mean pain during the latest 24 hours preceding the infiltration and the mean pain preceding the visit S4 (visit 4 weeks after the infiltration) week 4 No
Secondary To determine whether the improvement by the infiltration of corticoid is present at visit J7 (visit 7 days after the infiltration) and at visit S12 (visit 12 weeks after the infiltration) No
Secondary To determine whether an anesthetic positif bloc (decrease of the pain of more than 75 % during the hour that follows the infiltration) is a predictive factor of the final result No
Secondary To determine whether corticoïd infiltration can decrease the intake of drugs et decrease the functional handicap No